Jim A. Wright

Person

Toronto, CA

People

Patents Grantslast 30 patents

Information Patent Grant
Use of interleukin 17E for the treatment of cancer
- Patent number 8,287,851
- Issue date Oct 16, 2012
- Lorus Therapeutics Inc.
- Jim A. Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-indolyl imidazo [4,5-d] phenanthroline derivatives and their use...
- Patent number 8,148,392
- Issue date Apr 3, 2012
- Lorus Therapeutics Inc.
- Mario Huesca
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antisense oligonucleotides directed to ribonucleotide reductase R2...
- Patent number 7,968,526
- Issue date Jun 28, 2011
- Lorus Therapeutics Inc.
- Jim A. Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antitumor antisense sequences directed against R1 and R2 components...
- Patent number 7,405,205
- Issue date Jul 29, 2008
- Lorus Therapeutics Inc.
- Jim A. Wright
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oligonucleotides from the untranslated regions of housekeeping gene...
- Patent number 7,223,849
- Issue date May 29, 2007
- Genesense Technologies Inc.
- Jim A. Wright
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Neuropilin antisense oligonucleotide sequences and methods of using...
- Patent number 7,087,580
- Issue date Aug 8, 2006
- Genesense Technologies, Inc.
- Jim A. Wright
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antisense oligonucleotide sequences as inhibitors of microorganisms
- Patent number 6,610,539
- Issue date Aug 26, 2003
- Genesense Technologies, Inc.
- Jim A. Wright
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antitumor antisense sequences directed against R1 and R2 components...
- Patent number 6,593,305
- Issue date Jul 15, 2003
- Genesense Technologies Inc.
- Jim A. Wright
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Oligonucleotide sequences complementary to thioredoxin or thioredox...
- Patent number 6,566,514
- Issue date May 20, 2003
- Genesense Technologies Inc.
- Jim A. Wright
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Suppression of malignancy utilizing ribonucleotide reductase R1
- Patent number 6,472,376
- Issue date Oct 29, 2002
- Genesense Technologies, Inc.
- Jim A. Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Insulin-like growth factor II antisense oligonucleotide sequences a...
- Patent number 6,417,169
- Issue date Jul 9, 2002
- Genesense Technologies Inc.
- Jim A. Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antitumor antisense sequences directed against R1 and R2 components...
- Patent number 6,121,000
- Issue date Sep 19, 2000
- Genesense Technologies, Inc.
- Jim A. Wright
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Antitumor antisense sequences directed against ribonucleotide reduc...
- Patent number 5,998,383
- Issue date Dec 7, 1999
- Jim A. Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
USE OF INTERLEUKIN 17E FOR THE TREATMENT OF CANCER
- Publication number 20110158936
- Publication date Jun 30, 2011
- Lorus Therapeutics Inc.
- Jim A. Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SMALL INTERFERING RNA MOLECULES AGAINST RIBONUCLEOTIDE REDUCTASE AN...
- Publication number 20100204305
- Publication date Aug 12, 2010
- Lorus Therapeutics Inc.
- Aiping H. YOUNG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antisense Oligonucleotides Directed to Ribonucleotide Reductase R2...
- Publication number 20100197766
- Publication date Aug 5, 2010
- Lorus Therapeutics Inc.
- Jim A. WRIGHT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-Indolyl Imidazo [4,5-d] Phenanthroline Derivatives and Their Use...
- Publication number 20100168417
- Publication date Jul 1, 2010
- Mario Huesca
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antisense Oligonucleotides Directed to Ribonucleotide Reductase R2...
- Publication number 20090118205
- Publication date May 7, 2009
- Lorus Therapeutics Inc.
- Jim WRIGHT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antisense Oligonucleotides Directed to Ribonucleotide Reducatase R2...
- Publication number 20080311126
- Publication date Dec 18, 2008
- Genesense Technologies, Inc
- Aiping H. Young
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Small Interfering Rna Molecules Against Ribonucleotide Reductase an...
- Publication number 20080255065
- Publication date Oct 16, 2008
- GENESENSE TECHNOLOGIES, INC.
- Aiping H. Young
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Antisense Oligonucleotides Directed to Ribonucleotide Reductase R1...
- Publication number 20070274947
- Publication date Nov 29, 2007
- Aiping H. Young
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Vector utilizing ribonuclease reductase UTR and use for inhibiting...
- Publication number 20070032442
- Publication date Feb 8, 2007
- GENESENSE TECHNOLOGIES INC.
- Jim A. Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antitumor antisense sequences directed against R1 and R2 components...
- Publication number 20040009948
- Publication date Jan 15, 2004
- GENESENSE TECHNOLOGIES INC.
- Jim A. Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Suppression of malignancy utilizing ribonucleotide reductase R1
- Publication number 20030087866
- Publication date May 8, 2003
- GENESENSE TECHNOLOGIES INC.
- Jim A. Wright
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NEUROPILIN ANTISENSE OLIGONUCLEOTIDE SEQUENCES AND METHODS OF USING...
- Publication number 20030083274
- Publication date May 1, 2003
- JIM A. WRIGHT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Insulin-like growth factor II antisense oligonucleotide sequences a...
- Publication number 20020187954
- Publication date Dec 12, 2002
- GENESENSE TECHNOLOGIES INC.
- Jim A. Wright
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
SUPRESSION OF MALIGNANCY UTILIZING RIBONUCLEOTIDE REDUCTASE R1
- Publication number 20020004488
- Publication date Jan 10, 2002
- JIM A. WRIGHT
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Jim A. Wright

Person

Patents Grantslast 30 patents

Use of interleukin 17E for the treatment of cancer

2-indolyl imidazo [4,5-d] phenanthroline derivatives and their use...

Antisense oligonucleotides directed to ribonucleotide reductase R2...

Antitumor antisense sequences directed against R1 and R2 components...

Oligonucleotides from the untranslated regions of housekeeping gene...

Neuropilin antisense oligonucleotide sequences and methods of using...

Antisense oligonucleotide sequences as inhibitors of microorganisms

Antitumor antisense sequences directed against R1 and R2 components...

Oligonucleotide sequences complementary to thioredoxin or thioredox...

Suppression of malignancy utilizing ribonucleotide reductase R1

Insulin-like growth factor II antisense oligonucleotide sequences a...

Antitumor antisense sequences directed against R1 and R2 components...

Antitumor antisense sequences directed against ribonucleotide reduc...

Patents Applicationslast 30 patents

USE OF INTERLEUKIN 17E FOR THE TREATMENT OF CANCER

SMALL INTERFERING RNA MOLECULES AGAINST RIBONUCLEOTIDE REDUCTASE AN...

Antisense Oligonucleotides Directed to Ribonucleotide Reductase R2...

2-Indolyl Imidazo [4,5-d] Phenanthroline Derivatives and Their Use...

Antisense Oligonucleotides Directed to Ribonucleotide Reductase R2...

Antisense Oligonucleotides Directed to Ribonucleotide Reducatase R2...

Small Interfering Rna Molecules Against Ribonucleotide Reductase an...

Antisense Oligonucleotides Directed to Ribonucleotide Reductase R1...

Vector utilizing ribonuclease reductase UTR and use for inhibiting...

Antitumor antisense sequences directed against R1 and R2 components...

Suppression of malignancy utilizing ribonucleotide reductase R1

NEUROPILIN ANTISENSE OLIGONUCLEOTIDE SEQUENCES AND METHODS OF USING...

Insulin-like growth factor II antisense oligonucleotide sequences a...

SUPRESSION OF MALIGNANCY UTILIZING RIBONUCLEOTIDE REDUCTASE R1